Recombinant Mouse Cd209a Protein，His

CD209a, also known as DC-SIGN (Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin), is a C-type lectin receptor primarily expressed on dendritic cells and certain other immune cells. It plays a critical role in the immune response by recognizing and binding to a variety of pathogens, including viruses, bacteria, and fungi. Research surrounding CD209a has gained significant attention due to its involvement in both pathogen recognition and immune regulation. Its unique ability to modulate T-cell responses makes it a potential target for vaccine development and immunotherapy. Additionally, CD209a's interactions with HIV and other viruses underline its significance in the pathogenesis of infectious diseases. The study of recombinant CD209a protein has become paramount for exploring its structural and functional characteristics, aiding in the understanding of its role in immune interactions. This research not only contributes to basic immunology but also holds promise for innovative therapeutic strategies targeting infectious and inflammatory diseases. The development of recombinant forms of CD209a allows for detailed investigations into its binding properties, signaling mechanisms, and potential applications in drug delivery systems and vaccine design, thereby making it a valuable focus in both basic and applied biomedical research.